Tapping and peg insertion after levodopa intake in treated and de novo parkinsonian patients

Canadian Journal of Neurological Sciences

Volumn 29, Issue 1, 2002, Pages 73-77

  Müller, Thomas ^a   Benz, Sabiene ^a   Przuntek, Horst ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; DOMPERIDONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HAND MOVEMENT; HUMAN; MALE; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; SIDE EFFECT; SYMPTOMATOLOGY; TASK PERFORMANCE; TREATMENT OUTCOME;

EID: 0036199554     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100001761     Document Type: Article

References (57)

1. Scales for rating motor impairment in Parkinson's disease: Studies of reliability and convergent validity
2. Getting a grasp on research: Does treatment taint testing of parkinsonian patients?
3. Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter study
4. Reliability of the Columbia scale for assessing signs of Parkinson's disease
5. The clinimetrics of hypokinesia in Parkinson's disease: Subjective versus objective assessment
6. Long-term measurement of tremor
7. Where to record motor activity: An evaluation of commonly used sites of placement for activity monitors
8. Test-retest reliability of the Purdue Pegboard test
9. Purdue Pegboard and differential diagnosis
10. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
11. Concentration-effect relationship of levodopa-benserazide dispersible formulation versus standard form in the treatment of complicated motor response fluctuations in Parkinson's disease
12. Sublingual apomorphine in Parkinson's disease: A clinical and pharmacokinetic study
13. Disturbances of rhythm formation in patients with Parkinson's disease: Part I. Characteristics of tapping response to the periodic signals
14. The finger-tapping test. A quantitative analysis
15. Core assessment program for intracerebral transplantations (CAPIT)
16. Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: A two-year follow-up study of previously untreated patients
17. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases
18. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: Implications for the pathogenesis of the on-off phenomenon
19. Challenge tests to predict the dopaminergic response in untreated Parkinson's disease
20. Domperidone and Parkinson's disease
21. Tolcapone increases maximum concentration of levodopa
22. Correlation between tapping and inserting of pegs in Parkinson's disease
23. Determinants of tapping speed in normal control subjects and subjects with Parkinson's disease: Differing effects of brief and continued practice
24. Effect of practice on performance of a skilled motor task in patients with Parkinson's disease
25. 123I]-iodolisuride SPET visualizes dopaminergic loss in de novo parkinsonian patients: Is it a marker of striatal pre-synaptic degeneration?
26. The execution of bimanual movements in patients with Parkinson's, Huntington's and cerebellar disease
27. Enhanced fatigue during motor performance in patients with Parkinson's disease
28. Gastrointestinal dysfunction in Parkinson's disease
29. 123I]-β-CIT SPECT data
30. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy
31. Mid-stage parkinsonism with mild motor fluctuations
32. Dopamine autoreceptor function is lost in advanced Parkinson's disease
33. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys
34. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]raclopride
35. Internal versus external cues and the control of attention in Parkinson's disease
36. Cognitive function in Parkinson's disease: From description to theory
37. The neurobiological basis of movement initiation
38. Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases
39. Attentional functions in multiple system atrophy and Parkinson's disease
40. Cognitive deficits in Parkinson's disease
41. Dual task performance and processing resources in normal subjects and patients with Parkinson's disease
42. Do cognitive changes of Parkinson's disease result from dopamine depletion?
43. Quantitative assessment of bradykinesia in patients with Parkinson's disease
44. L-Dopa-induced sedation: A double-blind crossover controlled study versus triazolam and placebo in healthy volunteers
45. Waking up to sleep episodes in Parkinson's disease
46. Sleep attacks and Parkinson's disease treatment
47. Yawning as an aura for an L-dopa-induced "on" in Parkinson's disease
48. A study of tolerance to apomorphine
49. Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: An electrophysiological investigation
50. Pharmacologic strategies for augmenting cognitive performance in schizophrenia
51. The pharmacology of memory
52. Dopaminergic modulation of cholinergic responses in rat medial prefrontal cortex: An electrophysiological study
53. Amount and distribution of dietary protein affects clinical response to levodopa in Parkinson's disease
54. A balanced carbohydrate: Protein diet in the management of Parkinson's disease
55. The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers
56. Lamotrigine trial in idiopathic parkinsonism: A double-blind, placebo-controlled, crossover study
57. Voluntary movement after pallidotomy in severe Parkinson's disease